SCHEMBL7740522

SCHEMBL7740522

CC(C)(C)OC(=O)N(Cc1cc([N+](=O)[O-])ccc1-n1cccc1)C(=O)OC(C)(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.43
TDP1 Q9NUW8 4/20 0.43
ITGA4 P13612 1/20 0.41
ITGB7 P26010 1/20 0.41
MAPT P10636 4/20 0.41
HTT P42858 1/20 0.41
ALOX5 P09917 1/20 0.39
ALDH1A1 P00352 5/20 0.39
SMN1; SMN2 Q16637 3/20 0.37
LMNA P02545 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
MCOLN3 Q8TDD5 1/20 0.37
GABRA1 P14867 1/20 0.37
GABRG2 P18507 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6680614 0.84 ALDH1A1 (0.52) NPSR1MAPTHTTALDH1A1SMN1; SMN2
SCHEMBL7742120 0.84 ALDH1A1 (0.44) NPSR1ITGA4ITGB7MAPTHTT
SCHEMBL6675790 0.83 ALDH1A1 (0.54) NPSR1MAPTHTTALDH1A1SMN1; SMN2
SCHEMBL6677398 0.83 ITGA4 (0.43) TDP1ITGA4ITGB7MAPTHTT
SCHEMBL6681036 0.83 ALDH1A1 (0.45) NPSR1TDP1ITGA4ITGB7MAPT
SCHEMBL6676629 0.82 ALDH1A1 (0.45) ITGA4ITGB7MAPTHTTALOX5
SCHEMBL6674892 0.82 MEN1 (0.44) NPSR1ITGA4ITGB7MAPTALOX5
SCHEMBL27495191 0.82 TDP1 (0.48) NPSR1TDP1MAPTHTTALDH1A1
SCHEMBL6681796 0.81 ALDH1A1 (0.49) ITGA4ITGB7MAPTHTTALOX5
SCHEMBL6676364 0.81 TP53 (0.43) ITGA4ITGB7MAPTHTTALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6414005-B1 BRAIN DISORDERS; ALZHEIMER'S DISEASE; PARKINSON'S DISEASE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2002-07-02 US disclosed
EP-1043312-A1 HETEROCYCLIC COMPOUNDS HAVING NOS INHIBITORY ACTIVITIES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2000-10-11 EP disclosed